A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.

NCT07450599 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

High-Risk Localized Prostate Cancer

Interventions

DRUG: Darolutamide
DRUG: ADT

Sponsor

Bayer